Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2005 Sep 30;36(5):280-3.
doi: 10.1157/13079151.

[Randomised clinical trial to evaluate the efficacy of a multi-factorial intervention to reduce hospitalisation and improve the quality of life of patients with heart failure]

[Article in Spanish]
C Brotons  1 , M Martínez, E Rayó, C Morralla, E Ballarín, E Pérez; Investigadores del Estudio IC-DOM
Affiliations
Randomized Controlled Trial

[Randomised clinical trial to evaluate the efficacy of a multi-factorial intervention to reduce hospitalisation and improve the quality of life of patients with heart failure]

[Article in Spanish]
C Brotons et al. Aten Primaria. .

Abstract
in English, Spanish

Objectives: To evaluate the efficacy of a multi-disciplinary non-pharmacological intervention to reduce cardiovascular mortality and hospital re-admissions due to heart failure.

Design: Randomised, open, controlled, parallel, multi-centre prospective clinical trial.

Setting: Sardenya Primary Care Centre (PCC), les Corts PCC, "El Remei" PCC (Vic Sud), Vall d'Hebron Hospital, Hospital Clínic, Vic Hospital, Hospital Dos de Maig.

Participants: 300 patients diagnosed with heart failure.

Intervention: Monthly home visits with intercalated phone calls from very well trained nursing staff to provide education on the illness and treatments, optimise therapy compliance, and inform on self-monitoring and management (especially early detection and treatment of decompensation).

Main measurements: Combined variable of mortality for cardiovascular reasons and re-hospitalisation due to heart failure (via Casualty and/or Admissions) at 1 year. Health-related quality of life.

Discussion: Open study, as it is impossible to mask the intervention. The home intervention is not too complex and is easily performed by well-trained health professionals. Its use could be generalised, if a clinically relevant degree of efficacy was shown.

Objetivos: Evaluar la eficacia de una intervención multidisciplinaria no farmacológica para reducir la mortalidad cardiovascular y los reingresos hospitalarios por insuficiencia cardíaca.

Diseño: Ensayo clínico prospectivo, aleatorizado, abierto, controlado, paralelo y multicéntrico.

Emplazamiento: Centros de atención primaria Sardenya, Les Corts y Vic Sud «El Remei», y hospitales Vall d’Hebron, Clínic, Vic y Dos de Maig.

Participantes: Participarán 300 pacientes con el diagnóstico de insuficiencia cardíaca.

Intervención: Visitas domiciliarias mensuales con llamadas telefónicas intercaladas por personal de enfermería muy bien entrenado donde se proporcionará educación sobre la enfermedad y los tratamientos, optimización del cumplimiento terapéutico, educación sobre el autocontrol y el manejo (particularmente detección precoz y tratamiento de las descompensaciones).

Mediciones principales: Variable combinada de mortalidad por causa cardiovascular y rehospitalizaciones por insuficiencia cardíaca (urgencias y/o ingresos) al cabo de 1 año. Calidad de vida relacionada con la salud.

Discusión: Estudio de carácter abierto, ya que no es posible enmascarar la intervención. La intervención domiciliaria no es excesivamente compleja y puede ser realizada con facilidad por profesionales sanitarios bien entrenados; se podría generalizar su aplicación si se demostrara un grado de eficacia clínicamente relevante.

PubMed Disclaimer

References

    1. Rodríguez-Artalejo F., Guallar-Castillón P., Banegas J.R., Del Rey J. Trends in hospitalization and mortality for heart failure in Spain, 1980-1993. Eur Heart J. 1997;18:1771–1779. - PubMed
    1. Ho K.K.L., Anderson K.M., Kannel W.B., Grossman W., Levy D. Survival after the onset of congestive heart failure in Framingham Heart Study Subjects. Circulation. 1993;88:107–115. - PubMed
    1. Stafford R.S., Saglam D., Blumenthal D. National patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure. Arch Intern Med. 1997;157:2460–2464. - PubMed
    1. Edep M.E., Shah N.B., Tateo I.M., Massie B.M. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30:518–526. - PubMed
    1. Van Veldhuisen D.J., Charlesworth A., Crijns H.J.G.M., Lie Kl., Hampton J.R. Differences in drug treatment of chronic heart failure between European countries. Eur Heart J. 1999;20:666–672. - PubMed

Publication types